Single Analyte DAU Calibrator (5 mL) Norbuprenorphine: Cutoff Calibrator; IVD - for in vitro di...

FDA Device Recall #Z-1270-2014 — Class III — February 18, 2014

Recall Summary

Recall Number Z-1270-2014
Classification Class III — Low risk
Date Initiated February 18, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Lin-Zhi International Inc
Location Sunnyvale, CA
Product Type Devices
Quantity 120 units, 60 of each lot number

Product Description

Single Analyte DAU Calibrator (5 mL) Norbuprenorphine: Cutoff Calibrator; IVD - for in vitro diagnostic use only; Lin-Zhi International Sunnyvale, CA The Norbuprenorphine Drug of Abuse (DAU) cutoff Calibrator is used for qualitative and semi-qualitative calibration of the Lin-Zhi Internal, Inc. Buprenorphine (BUP) enzyme Immunoassay (REF # A53684) on the Synchron Clinical Analyzer

Reason for Recall

Customer reported that the Synchron NBUP cutoff calibrator (10 ng/mL) could not be qualified through quality control testing. The cutoff calibrator was recovering at a concentration close to the NBUP Control Level 1 (7 ng/mL).

Distribution Pattern

US Distribution including CA.

Lot / Code Information

Product catalog number: A68827; Lots 1308006, 1308131, Expiry: March 28, 2015.

Other Recalls from Lin-Zhi International Inc

Recall # Classification Product Date
Z-1256-2019 Class III Ethyl Alcohol Enzymatic Assay, (a) REF 0220 (sm... Jan 11, 2019
Z-1179-2014 Class II Cannabinoids DAU Calibrator Control Level 1 (... Feb 6, 2014
Z-1178-2014 Class II Cannabinoids DAU Calibrator Control Level 1 (... Feb 6, 2014
Z-0386-2014 Class III Single Analyte Urine DAU Control (5 m L Norbup... Oct 3, 2013

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.